New Delhi [India], June 2: Reinforcing its commitment to pioneering advanced cancer care, Sarvodaya Hospital, Faridabad, Delhi NCR is proud to announce that it has become the first Theranostics and Nuclear Medicine center in India to offer Terbium-161 PSMA therapy for prostate cancer treatme
Combining chemotherapy and hormonal therapy for patients with locally advanced prostate cancer provides longer control of prostate-specific antigen (PSA) levels than hormonal therapy alone, according to a study.
Ahmedabad (Gujarat) [India], January 30: Zydus Lifesciences Ltd., a global innovation-driven healthcare company announced that it has launched Relugolix under the brand name, Rexigo™. This is the first and only oral once-a-day therapy for testosterone suppression in patients with advan
Amsterdam [Netherlands], July 11 (ANI): A new research has found that obese patients with a form of advanced prostate cancer survive longer than overweight and normal-weight patients.
Washington D.C. [USA], Nov 30 (ANI): In what could be a piece of great news for men with advanced prostate cancer, a new study has claimed that they can live two more years or even more on immunotherapy.